The Promise and the Price
The healthcare revolution came quietly, dressed in the language of innovation and efficiency. AI diagnostic systems that could read scans with superhuman accuracy. Robotic surgical assistants that never tired. Virtual health assistants available 24/7, no appointment necessary. Remote monitoring devices that tracked your vitals in real-time, predicting health crises before they happened.
The pitch was irresistible: better care, lower costs, universal access. The reality emerging in 2025 tells a more complicated story—one where the machinery of modern medicine increasingly operates behind subscription paywalls, and where “access” means something very different depending on which tier you can afford.
The Subscription Medicine Paradigm
Healthcare has always had gatekeepers, but the new model represents a fundamental shift in how medical services are packaged and delivered.
Major tech companies and healthcare conglomerates are rolling out tiered subscription services that bundle AI diagnostics, remote monitoring, and robotic consultations into monthly plans. The basic tier might include virtual triage and AI-powered symptom checking. Mid-tier adds remote specialist consultations and predictive health analytics. Premium subscribers get priority access to robotic surgical systems, continuous health monitoring, and personalized treatment algorithms trained on the world’s most comprehensive medical datasets.
On the surface, it resembles the streaming services that revolutionized entertainment. Scroll through available providers, select your plan, update your payment method. The difference, of course, is that you can live without Netflix. Healthcare operates under a different calculus of need.
The Robot Will See You Now—If You’re Paid Up
Remote diagnostics have become remarkably sophisticated. Upload images of a suspicious mole, and AI dermatology systems can assess cancer risk with accuracy that rivals top specialists. Describe your symptoms to a chatbot, and natural language processing algorithms can triage you more consistently than many urgent care facilities.
But here’s where the model reveals its fault lines: these diagnostic tools aren’t being deployed as public utilities. They’re proprietary systems, owned by private companies, operated for profit. Access requires a subscription, and the quality of the AI you get to consult—the depth of its training data, the sophistication of its algorithms—scales with what you pay.
A patient with a premium subscription might get diagnostic analysis from AI models trained on millions of diverse patient cases, including rare conditions and edge cases. The budget-tier subscriber gets the basic model, trained on more limited datasets, potentially missing nuances that could matter for their specific situation.
The robot clinician doesn’t judge you for your inability to pay—it simply won’t see you at all.
The Erosion of Universal Healthcare Infrastructure
Perhaps most concerning is how subscription-based remote diagnostics are reshaping the broader healthcare landscape.
As tech companies siphon off patients who can afford premium AI-powered care, traditional healthcare infrastructure faces new pressures. Why maintain expensive emergency departments when many routine cases can be handled by AI triage systems—for those who subscribe? Why invest in training radiologists when automated image analysis can process scans faster and cheaper—if you’re enrolled in the right plan?
Some regions are already seeing hospital closures justified partly by the availability of “alternative digital care options.” Rural communities, already underserved, find themselves further marginalized. The local clinic that once provided basic care can’t compete with AI platforms that offer 24/7 access and instant consultations—but only to those with reliable internet, devices, and recurring payments.
The promise was democratization. The reality increasingly resembles market segmentation.
The Algorithmic Care Ceiling
There’s another dimension to this robot-driven healthcare eternity: the limitations of algorithmic medicine itself.
AI systems excel at pattern recognition within their training parameters. They can spot anomalies in imaging, flag concerning symptoms, and predict likely diagnoses based on population-level data. What they cannot do—at least not yet—is exercise the kind of contextual judgment, intuitive reasoning, and empathetic understanding that characterizes the best of human medicine.
A virtual health assistant might correctly identify that your symptoms match a common condition 90% of the time. But what about the 10% of cases where context matters—where your specific medical history, your genetic background, your living situation, or your psychological state are crucial factors that don’t fit neatly into algorithmic boxes?
In a subscription model optimized for efficiency and scale, who handles the edge cases? Who takes the time for the complicated patient whose condition doesn’t fit the pattern? The risk is that we’re building a healthcare system designed for the average case, with increasingly limited pathways for those who fall outside algorithmic expectations.
The Data Extraction Economy
Subscription healthcare isn’t just about accessing services—it’s about generating data.
Every interaction with a diagnostic AI, every reading from a wearable monitor, every symptom logged in an app becomes training data that makes the algorithms more valuable. Patients aren’t just paying for care; they’re producing the data that makes better care possible for future subscribers.
Yet the value generated by this data doesn’t flow back to patients. It accrues to the platforms that own the systems. Your genetic information, your health history, your treatment outcomes—all feed into proprietary databases that companies use to refine their products and justify premium pricing tiers.
The arrangement raises uncomfortable questions about who owns health data, who profits from it, and whether patients are being fairly compensated for their contribution to medical AI development. In the subscription model, you pay monthly for the privilege of making the service more valuable.
When the Algorithm Says No
Insurance companies have long been gatekeepers of healthcare access, but algorithmic decision-making introduces new kinds of barriers.
AI diagnostic systems are trained to optimize for efficiency and standardized care pathways. When a patient’s situation is complex or expensive, algorithms might flag them as “high-risk” or “low-value” subscribers. Automatic risk scoring could result in higher premiums, denied coverage, or downgraded service tiers.
The decision isn’t made by a human being exercising judgment—it’s spit out by an optimization algorithm that sees patients as data points. Appeal processes become exercises in arguing with code. When the robot says your treatment isn’t covered under your subscription tier, who do you appeal to?
The Equity Trap
Subscription-based remote diagnostics create a feedback loop that entrenches existing health inequalities.
Wealthier patients who can afford premium subscriptions get access to the most advanced AI diagnostics, the most personalized treatment recommendations, and the best health outcomes. Their data—reflecting the health patterns of affluent populations—trains the algorithms to work better for people like them.
Lower-tier subscribers get less sophisticated care and generate data that reflects the health challenges of under-resourced populations. But because budget tiers use less advanced algorithms trained on more limited datasets, the system becomes progressively worse at serving disadvantaged groups.
The gap widens not because anyone intended it, but because the economic logic of subscription services naturally optimizes for customers who can pay more. Healthcare inequality becomes algorithmically reinforced.
Resistance and Alternatives
Not everyone is accepting this trajectory without pushback.
Some regions are exploring public AI healthcare utilities—diagnostic systems owned and operated as public services rather than commercial products. Open-source medical AI projects aim to create diagnostic tools that aren’t locked behind paywalls. Healthcare cooperatives are forming to collectively bargain for better subscription terms or develop alternative models.
Labor unions representing healthcare workers are raising alarms about the deskilling of medical professions and the erosion of jobs that provided middle-class stability. They’re advocating for regulations that preserve human oversight in medical decision-making and prevent the wholesale automation of care delivery.
Patient advocacy groups are demanding transparency in how medical AI systems make decisions, pushing for rights to explanation when algorithms affect treatment options, and calling for portable health data that patients can take between platforms.
The Fork in the Road
We stand at a critical juncture in healthcare’s evolution.
The technologies being deployed—remote diagnostics, AI-powered treatment planning, robotic care delivery—genuinely have potential to improve medical outcomes and expand access. Telemedicine can reach patients in remote areas. AI can catch diseases earlier. Automation can reduce costs.
But technology doesn’t determine how it’s used. Business models do. Policy choices do. Social values do.
The question isn’t whether robots and AI will play a role in future healthcare. They already do. The question is whether that role will serve universal health needs or commercial interests—whether remote diagnostics become a public good or a premium service, whether algorithmic care serves population health or subscription revenue.
The Human Alternative
There’s another possible future, one where healthcare automation serves equity rather than market segmentation.
In this version, AI diagnostic tools are deployed as public health infrastructure, free at the point of use like roads or libraries. Remote monitoring helps catch diseases early across all populations, not just those who can afford premium plans. Algorithmic care recommendations are transparent, auditable, and designed with input from diverse communities.
Healthcare workers aren’t displaced but redeployed—freed from routine tasks to focus on complex cases, emotional support, and the irreducibly human dimensions of medicine. Robots handle logistics and repetition; humans handle judgment and care.
Data generated by patients contributes to medical knowledge as a commons, not a proprietary asset. The benefits of more sophisticated AI are shared broadly rather than locked behind subscription tiers.
Conclusion: Choose Your Eternity
The “robot-driven eternity” of the title isn’t inevitable. It’s a choice being made right now, in boardrooms and policy meetings, through business model decisions and regulatory frameworks.
We can build a healthcare future where automation reduces costs that are then passed on to patients in the form of universal access. Or we can build one where cost savings become corporate profits while access gets paywalled.
We can create diagnostic AI that works equally well for all populations, trained on diverse datasets and deployed as public infrastructure. Or we can accept a system where the quality of your AI doctor depends on your credit card limit.
The technology will continue advancing regardless. The eternity we’re building—who it serves, who it excludes, whether it heals or merely extracts—that’s up to us.
The subscription model promises convenience and innovation. But before we sign on the dotted line, we should read the terms of service carefully. Some contracts bind you forever. Some kinds of access, once lost, are hard to regain. And some prices, though payable monthly, accumulate into costs too high to bear.
The robots are ready to see us now. The question is whether they’re working for us—or whether we’re all just users in someone else’s platform, subscribing to the health we can afford until the payment lapses and the connection drops.
Opinion essay examining emerging trends in AI healthcare delivery and business models, December 2024